inqaba biotec

What inqaba biotec does

inqaba biotec (legal name: Inqaba Biotechnical Industries (Pty) Ltd) is a sub-Saharan African genomics and life science distribution company founded in 2002 and headquartered in Pretoria, South Africa. The company operates as both a commercial genomics services provider and a multi-brand distributor, serving academic researchers, clinical laboratories, agricultural research institutions, and conservation programs across at least eight African countries (South Africa, Nigeria, Kenya, Ghana, Tanzania, Uganda, Cameroon, Senegal) through wholly-owned regional subsidiaries. Service offerings include Next Generation Sequencing (PacBio Revio, Onso, and NextSeq platforms), Sanger sequencing (dual ABI 3500XL, 10,000+ reads/month capacity), MassARRAY SNP genotyping, qPCR analysis, fragment analysis, oligonucleotide synthesis (15+ years of experience), microarray processing, animal genetics via the ZooOmics partnership, and customized bioinformatics analysis using DNASTAR and Advaita software. The Revio system, acquired in 2024 with UNISA, gives capacity for approximately 1,300 human-sized genomes per year with Q40+ data quality.

The company's revenue model blends fee-for-service genomics, quote-based project work, and hardware/consumables/reagent distribution across sub-Saharan Africa. It is the exclusive or principal regional distributor for a portfolio of global life science brands including Pacific Biosciences (PacBio), Eppendorf, New England Biolabs, Zymo Research, Seegene, Agena Bioscience, Shoreline Biome, Nolato Treff, Biomatik, and others, complemented by instrument servicing, micro-pipette calibration, and applied training workshops in phylogenetics, bioinformatics, and NGS techniques. Customer segments are weighted toward academic and research institutions (universities, research institutes) and healthcare/clinical laboratories, with secondary exposure to agricultural/veterinary research and early-career life science trainees.

Go-to-market is sales-led and enterprise-focused: regional field sales teams in each subsidiary market, supported by an online self-serve portal for oligo ordering, an expanding program of scientific conference participation (SASBMB-FASBMB, East Africa Health and Scientific Conference, International Congress of Human Genetics), and recurring training/workshop programs (rare disease workshops, NGS data analysis courses) that also serve as demand generation. The company is privately held, founder-led (Executive Director Dr Oliver Preisig, Co-founder Dr Joaquim de Gama), and was bootstrapped through a 2001 seed round of CHF 250,000 from the Swiss State Secretariat for Economic Affairs (SECO) plus private investors in Germany, South Africa, and Switzerland, with Standard Bank providing ZAR 4 million in lease funding for initial lab equipment. A pivot to in-house manufacturing is signaled by the planned late-2026 commissioning of the Autarky Consumables plastic laboratory consumables facility.

Name

inqaba biotec

Legal name

Inqaba Biotechnical Industries (Pty) Ltd

Website

https://inqababiotec.co.za

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

101–250 employees

Short description

inqaba biotec is a South African genomics and life science distribution company that provides DNA sequencing, oligo synthesis, and bioinformatics services across sub-Saharan Africa, while also distributing reagents, instruments, and diagnostics from global brands like PacBio, Eppendorf, and NEB to African researchers.

Ownership category

akta.pro rank

Product category

Genomics Services

NAICS

Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

akta.pro secondary industries

Microbiome & Metagenomics Services (HLAGANAH), Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF), Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal) (HLAAAFAH)

Keywords

• DNA sequencing services
• Oligonucleotide synthesis
• Life science distribution
• Genomics research services
• Molecular diagnostics

Headquarters

HQ city

Gauteng

HQ country

South Africa

HQ region

Africa

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. DNA Sequencing Services: Commercial DNA sequencing services including Sanger sequencing (10,000+ reads/month capacity) and Next Generation Sequencing (PacBio HiFi, short read) services. Services range from single reactions to whole genome projects with flexible tiers.
2. Oligo Synthesis: Custom oligonucleotide synthesis services with over 15 years of experience, offering fastest delivery in South Africa with 100% satisfaction guarantee
3. Life Science Products Distribution: Distribution of molecular biology reagents, equipment, consumables and molecular diagnostics products from international brands including Eppendorf, New England Biolabs, Zymo Research, PacBio, Seegene across sub-Saharan Africa
4. Molecular Diagnostics: Diagnostic kits and testing services for respiratory, gastrointestinal, infectious diseases and other clinical applications
5. Training and Workshops: Practical application training in molecular biology including introductory phylogenetics, molecular techniques, bioinformatics and NGS courses
6. Instrument Services: Maintenance, service, repair and calibration of laboratory instruments including pipette calibration services

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

inqaba biotec is a sub-Saharan African genomics company that provides commercial DNA sequencing services (Sanger, NGS/PacBio), custom oligonucleotide synthesis, bioinformatics analysis, qPCR, fragment analysis, MassARRAY genotyping, microarray processing, and animal genetics. It also distributes molecular biology reagents, instruments, and molecular diagnostics products from global brands across the region.

Product overview

Inqaba biotec is a South African genomics company providing a comprehensive portfolio of DNA/RNA sequencing and synthesis services alongside distribution of life science consumables and instruments. The core service offering includes Next Generation Sequencing (using PacBio Revio, Onso, and NextSeq platforms), Sanger Sequencing, Oligo Synthesis, MassARRAY Genotyping, qPCR Analysis, Fragment Analysis, Bioinformatics, Animal Genetics, Instrument Services, Workshops, and Microarray Services. The company distributes products from major global brands including Eppendorf, Zymo Research, PacBio, Seegene, New England Biolabs, DNASTAR, and Advaita. Inqaba biotec operates as a service provider and distributor, with plans to launch in-house manufacturing of plastic laboratory consumables in late 2026.

Differentiator

Problem solved

Functional benefit

Products and services

• Next Generation Sequencing (NGS) Comprehensive NGS services including whole genome sequencing, transcriptome sequencing, targeted sequencing, metagenomics, and epigenetics using PacBio Revio, Onso, and NextSeq platforms for research institutions and clinical labs.
• Sanger Sequencing DNA sequencing services using ABI 3500XL genetic analyser producing more than 10,000 reads per month for researchers and clinical laboratories.
• Oligo Synthesis Custom oligonucleotide synthesis with fastest delivery in South Africa and 100% satisfaction guarantee, serving researchers needing DNA synthesis for PCR, sequencing, and molecular biology applications.
• MassARRAY Genotyping Medium to high throughput SNP detection using Agena Bioscience MassARRAY System with MALDI-TOF analysis, supporting up to 36 SNPs per plex, copy number variation, and methylation analysis.
• qPCR Analysis Real-time PCR services including gene expression analysis, SNP genotyping, and absolute quantification with RNA/DNA extraction and assay development.
• Fragment Analysis Capillary-based fragment analysis using ABI 3500XL genetic analyser for DNA fingerprinting, indel mutation analysis, and multiplex PCR reactions with high-throughput marker analysis capacity.
• Bioinformatics Customized bioinformatics analysis services for NGS data interpretation using DNASTAR and Advaita bioinformatics software, covering analysis, training, and project support.
• Microarray Service Automated microarray processing using GeneTitan instrument with Affymetrix HT Array Plates for genome-wide SNP genotyping and gene expression profiling.
• Instrument Services Maintenance, service, and repair for instruments including Eppendorf, Vilber Lourmat, Seegene, and NanoDrop equipment, including micro-pipette calibration and tailored maintenance plans.
• Workshops and Training Practical application training in molecular biology including introductory phylogenetics workshops, molecular techniques courses, and PacBio HiFi sequencing courses for graduate students and researchers.
• Life Science Products Distribution Distribution of molecular biology reagents, DNA/RNA isolation kits, biochemicals, cell culture solutions, ELISA kits, antibodies, proteins, CRISPR products, and laboratory plastics from global brands across sub-Saharan Africa.
• Molecular Diagnostics Distribution Distribution of molecular diagnostic products including Seegene multiplex qPCR kits, Devyser genetic testing kits, Vircell infectious disease diagnostics, Bio-Rad clinical diagnostics, and OGT FISH probes and NGS panels.

Quantifiable outcome

• 10,000+ Sanger sequencing reads per month capacity
• +4 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

13 partnerships are on record, tiered flagship, core and minor.

• University of South Africa (UNISA)flagshipStrategic or Co-development Partner · 17 July 2024Joint partnership for acquisition and operation of Africa's first PacBio Revio sequencing platform. Capital cost jointly shared, located at Inqaba Biotec facilities in Pretoria and jointly operated. Represents mutual commitment to advancing scientific research.
• Pacific Biosciences (PacBio)coreTechnology or Integration · 22 November 2023Certified Sequencing Service provider partnership for superior long read (HiFi) sequencing on Sequel IIe system. Expanded to include Revio system in 2024 - Africa's first PacBio Revio platform. Partnership enables access to cutting-edge sequencing technologies for African researchers.
• Shoreline BiomecoreChannel Partner/ Reseller/ Distributor · 4 June 2021Product distribution and StrainID services partnership for microbiome research products in Sub-Saharan Africa. Enables provision of easy-to-use microbiome kits and software to customers with strain-level identification capabilities using PacBio Sequel IIe.
• Zymo ResearchcoreChannel Partner/ Reseller/ Distributor · 1 January 2006Exclusive distribution partnership for DNA and RNA purification, epigenetics, microbiomics, and NGS solutions in sub-Saharan Africa since 2006. Zymo Research products include DNA/RNA Shield, ZymoPURE, Direct-Zol and complete microbiome portfolio.
• New England Biolabs (NEB)coreChannel Partner/ Reseller/ DistributorDistribution partnership for recombinant enzymes and reagents for molecular biology applications. Partnership celebrating 10 years in 2024 with co-sponsored events at International Congress of Human Genetics.
• EppendorfcoreChannel Partner/ Reseller/ DistributorDistribution partnership for pipettes, centrifuges, thermal cyclers and other life science equipment across Africa.
• Agena BiosciencecoreTechnology or IntegrationPartnership to introduce MassARRAY technology in sub-Saharan Africa for SNP genotyping and methylation analysis. System uses MALDI-TOF mass spectrometry with single base-extension chemistry.
• CERI (Centre for Human Genetics, Stellenbosch University)minorStrategic or Co-development PartnerCollaboration for rare disease workshop on NGS data analysis and interpretation for rare genetic disorders, presented by Prof. Alex Hoischen and Prof. Christian Gilissen from Radboudumc.
• African BioGenome Project (ABP)flagshipStrategic or Co-development PartnerPartnership for genome challenge initiatives supporting African biodiversity. Inqaba biotec sponsoring PacBio SMRT cells for sequencing African eukaryotic genomes. Joint effort for 2021 and 2022 genome challenges.
• Seegene DiagnosticscoreChannel Partner/ Reseller/ DistributorDistribution of multiplex qPCR diagnostic kits for respiratory, gastrointestinal, and infectious disease panels. Products include Allplex and Anyplex real-time PCR platforms and Seeplex automated capillary electrophoresis diagnostics.
• BIOREBAminorChannel Partner/ Reseller/ DistributorDistribution of solutions for detection of plant pathogens including validated products for testing potatoes, vines, fruit trees, vegetables, and field crops.
• Bernhard Notch Institute for Tropical Medicine (BNITM)minorStrategic or Co-development PartnerTraining collaboration in Hamburg for diagnostics of communicable diseases as part of East African Community Regional Network initiative funded by German Development Bank.
• Nolato Treff AGminorChannel Partner/ Reseller/ DistributorDistribution of premium TreffLab plastics including 96-well plates, microtubes, pipette tips, cryogenic tubes. Products manufactured in ISO 14644-1 class 8 sterile environments, free of RNase, DNase, endotoxins and human DNA.

Scale indicators10 records

Recent moves14 records

Expansion highlights6 records

Direct peers

• Macrogen: Korea-headquartered genomics services company offering Sanger, NGS, oligo synthesis and bioinformatics globally; structurally closest comparable to Inqaba as a sequencing-led services company serving research and clinical customers.
• GENEWIZ (Azenta Life Sciences): Global genomics services provider (now part of Azenta) offering Sanger, NGS, gene synthesis and bioinformatics to research customers; very similar service model to Inqaba's research-led segments.
• Source BioScience: UK-based genomics and laboratory services company offering Sanger, NGS and clinical diagnostics; closely comparable in service mix and customer profile (academic, clinical, pharma).

Regional players

• Ampath: Major South African pathology and diagnostic laboratory group; relevant regional competitor and customer overlap for Inqaba's clinical diagnostics and molecular testing offerings.
• Lancet Laboratories: Leading South African clinical diagnostics and pathology laboratory network; comparable regional peer for Inqaba's molecular diagnostics and clinical lab services across Southern Africa.

Emerging players

• 54gene: Nigeria-founded genomics and molecular diagnostics company focused on African populations; emerging African competitor with overlapping ambitions in clinical genomics and biorepository.

Broad incumbents

• Eurofins Genomics: Global commercial DNA sequencing, oligo synthesis and bioinformatics services provider; comparable to Inqaba's core service portfolio but at vastly larger scale across Europe, North America and Asia.
• BGI Genomics: China-based global genomics powerhouse offering sequencing services, instruments and diagnostics; competes for large-scale genomics projects and represents a long-term competitive threat as African capacity matures.
• Novogene: Large global NGS services provider with PacBio and Illumina platforms serving academic and pharma customers; overlaps with Inqaba's NGS and bioinformatics offerings at much greater scale.

Others

• Inqaba Biotec's own ZooOmics division: Listed for completeness as Inqaba's own animal/wildlife genetics arm; reflects the company's diversification beyond human genomics into agricultural and conservation genetics, which mirrors peers in animal genomics services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/inqababiotec
• YouTubeyoutube.com/channel/UCFYkwbO3go46KC5HKyRGRmw
• Facebookfacebook.com/InqabaBiotec
• LinkedInlinkedin.com/company/inqaba-biotec

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about inqaba biotec